Corporate Social Responsibility (CSR) activities have been revealed as an emerging managerial tool and research field. The socioeconomic impact of the COVID-19 pandemic has prompted several companies to take on CSR initiatives. The objective of this study was to investigate CSR initiatives implemented in companies specializing in pharmaceutical and biomedical products as well as medical equipment, prior and during the COVID-19 pandemic. A cross-sectional study was conducted in companies of the Hellenic Association of Pharmaceutical Companies (SFEE), the Panhellenic Association of Pharmaceutical Industry (PEF) and the Association of Health-Research and Biotechnology Industry (SEIV). A self-administered questionnaire was distributed to a total of 112 companies. Descriptive and multivariate statistical analyses were performed using SPSS 25.0. Levels of significance were two-tailed and statistical significance was set at p = 0.05. The final sample consisted of 74 companies with a response rate of 77.7%. Among them 62.2% were multinational and 37.8% national companies. Some companies provided pharmaceuticals (40.5%), medical equipment and biotechnology products (32.4%) and others were specializing in both categories (27.1%). A percentage equal to 89.2% stated that they implemented CSR activities, out of which 75.7% carried out COVID-19 related initiatives, such as in public health (37.7%), societal issues (27.2%), environment (19.9%), etc. Approximately 50% increased their CSR activities during the pandemic. Moreover, the majority of companies devoted ≤30% of their total CSR budget against the pandemic. The higher a company’s turnover, the higher CSR activities performance. Pharmaceutical and biomedical companies in Greece implemented CSR actions, prior and during the pandemic. Companies contributed to handle the effects of health crisis through CSR Covid-19 related activities, which differentiated according to company’s culture and wealth. It is important that authorities should reward companies carrying out CSR initiatives, given that they positively contribute to the societal recovery by financially supporting the health care sector and the overall economy.
KeywordsCorporate Social Responsibility (CSR)PharmaceuticalsHealth TechnologyPublic HealthPandemic COVID-19Greece
McLennan, S. and Banks, G. (2019) Reversing the Lens: Why Corporate Social Responsibility Is Not Community Development. Corporate Social Responsibility and Environmental Management, 26, 117-126. https://doi.org/10.1002/csr.1664
Carroll, A.B. (2021) Corporate Social Responsibility (CSR) and the COVID-19 Pandemic: Organizational and Managerial Implications. Journal of Strategy and Management, 14, 315-330 https://doi.org/10.1108/JSMA-07-2021-0145
McWilliams, A., Siegel, D. and Wright, P. (2006) Corporate Social Responsibility: Strategic Implications. Journal of Management Studies, 43, 1-18. https://doi.org/10.1111/j.1467-6486.2006.00580.x
European Commission (2001) Promoting a European Framework for Corporate Social Responsibility. European Commission, Brussels. https://ec.europa.eu/commission/presscorner/detail/en/DOC_01_9
Bruna, M.G. and Lahouel, B.B. (2022) CSR & Financial Performance: Facing Methodological and Modeling Issues Commentary Paper to the Eponymous FRL Article Collection. Finance Research Letters, 44, Article ID: 102036. https://doi.org/10.1016/j.frl.2021.102036
Bruna, M.G. and Nicolò, D. (2020) Corporate Reputation and Social Sustainability in the Early Stages of Start-Ups: A Theoretical Model to Match Stakeholders’ Expectations through Corporate Social Commitment. Finance Research Letters, 35, Article ID: 101508. https://doi.org/10.1016/j.frl.2020.101508
Bae, K.-H., El Ghoul, S., Gong, Z. and Guedhami, O. (2021) Does CSR Matter in Times of Crisis? Evidence from the COVID-19 Pandemic. Journal of Corporate Finance, 67, Article ID: 101876. https://doi.org/10.1016/j.jcorpfin.2020.101876
World Health Organization (2021) WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization, Genève.
Baatwah, S.R., Al-Qadasi, A.A., Al-Shehri, A.M. and Derouiche, I. (2022) Corporate Social Responsibility Budgeting and Spending during COVID-19 in Oman: A Humanitarian Response to the Pandemic. Finance Research Letters, 47, Article ID: 102686. https://doi.org/10.1016/j.frl.2022.102686
Bapuji, H., Patel, C., Ertug, G. and Allen, D.G. (2020) Corona Crisis and Inequality: Why Management Research Needs a Societal Turn. Journal of Management, 46, 1205-1222. https://doi.org/10.1177/0149206320925881
Mahmud, A., Ding, D. and Hasan, M.M. (2021) Corporate Social Responsibility: Business Responses to Coronavirus (COVID-19) Pandemic. SAGE Open, 11. https://doi.org/10.1177/2158244020988710
Guerriero, C., Haines, A. and Pagano, M. (2020) Health and Sustainability in Post-Pandemic Economic Policies. Nature Sustainability, 3, 494-496. https://doi.org/10.1038/s41893-020-0563-0
He, H. and Harris, L. (2020) The Impact of Covid-19 Pandemic on Corporate Social Responsibility and Marketing Philosophy. Journal of Business Research, 116, 176-182. https://doi.org/10.1016/j.jbusres.2020.05.030
Droppert, H. and Bennett, S. (2015) Corporate Social Responsibility in Global Health: An Exploratory Study of Multinational Pharmaceutical Firms. Globalization and Health, 11, Article No. 15. https://doi.org/10.1186/s12992-015-0100-5
Sharma, P., Leung, T.Y., Kingshott, R.P., Davcik, N.S. and Cardinali, S. (2020) Managing Uncertainty during a Global Pandemic: An International Business Perspective. Journal of Business Research, 116, 188-192. https://doi.org/10.1016/j.jbusres.2020.05.026
Ducharme, J. (2020) World Health Organization declares COVID-19 a “Pandemic.” Here’s What That Means. The Time. https://time.com/5791661/who-coronavirus-pandemic-declaration/
Kritas, D., Tzagkarakis, S., Atsipoulianaki, Z. and Sidiropoulos, S. (2020) The Contribution of CSR during the Covid-19 Period in Greece: A Step Forward. HAPSc Policy Briefs Series, 1, 238-243. https://doi.org/10.12681/hapscpbs.24971
Foundation for Economic & Industrial Research (IOBE) (2022) The Pharmaceutical Market in Greece: Facts & Figures 2021.
Pouliopoulos, L., Geitona, M., Pouliopoulos, T. and Triantafillidou, A. (2012) Managers’ Perceptions and Opinions towards Corporate Social Responsibility (CSR) in Greece. Procedia Economics and Finance, 1, 311-320. https://doi.org/10.1016/S2212-5671(12)00036-6
Gallardo-Vázquez, D., Sánchez-Hernández, M.I. and Corchuelo-Martínez-Azúa, M.B. (2013) Validación de un instrumento de medida para la relación entre la orientación a la responsabilidad social corporativa y otras variables estratégicas de la empresa. Revista de Contabilidad, 16, 11-23. https://doi.org/10.1016/S1138-4891(13)70002-5
Rea, L.M. and Parker, R.A. (2014) Designing and Conducting Survey Research: A Comprehensive Guide. John Wiley & Sons, Hoboken.
Athanasiadis, T. (2022) Press Release: “The Pharmaceutical Market in Greece: Facts & Figures 2021”. https://policycommons.net/artifacts/2648154/deltio-tupou-e-pharmakeutike-agora-sten-ellada/3671001/
Maska, L., Tsekeris, T., Kadas, C. and Tsekeris, C. (2017) Measuring the Crisis Preparedness in the Pharmaceutical Sector: The Case of Greece. Zbornik Radova Veleucilista u Sibeniku, 3-4, 7-18.
Androutsou, L., Latsou, D. and Geitona, M. (2021) Health Systems’ Challenges and Responses for Recovery in the Pre and Post COVID-19 Era. Journal of Service Science and Management, 14, 444-460. https://doi.org/10.4236/jssm.2021.144028
Moris, D. and Schizas, D. (2020) Lockdown during COVID-19: The Greek Success. In Vivo, 34, 1695-1699. https://doi.org/10.21873/invivo.11963
Tellis, G.J. and Tellis, K. (2009) Research on Advertising in a Recession. Journal of Advertising Research, 49, 304-327. https://doi.org/10.2501/S0021849909090400
Panagiotopoulos, I. (2021) Novel CSR & Novel Coronavirus: Corporate Social Responsibility inside the Frame of Coronavirus Pandemic in Greece. International Journal of Corporate Social Responsibility, 6, Article No. 10. https://doi.org/10.1186/s40991-021-00065-7
García-Sánchez, I.M. and García-Sánchez, A. (2020) Corporate Social Responsibility during COVID-19 Pandemic. Journal of Open Innovation: Technology, Market, and Complexity, 6, Article No. 126. https://doi.org/10.3390/joitmc6040126
Aguinis, H., Villamor, I. and Gabriel, K.P. (2020) Understanding Employee Responses to COVID-19: A Behavioral Corporate Social Responsibility Perspective. Management Research: Journal of the Iberoamerican Academy of Management, 18, 421-438. https://doi.org/10.1108/MRJIAM-06-2020-1053
Brammer, S., Branicki, L. and Linnenluecke, M.K. (2020) COVID-19, Societalization, and the Future of Business in Society. Academy of Management Perspectives, 34, 493-507. https://doi.org/10.5465/amp.2019.0053
Kim, S. (2022) The COVID-19 Pandemic and Corporate Social Responsibility of Korean Global Firms: From the Perspective of Stakeholder Theory. Emerald Open Research, 4, Article No. 16. https://doi.org/10.35241/emeraldopenres.14511.1
García-Sánchez, I.M., García-Sánchez, A. and Asadi Lari, H. (2021) Corporate Social Responsibility during COVID-19 Pandemic. Social Security Journal, 17, 203-232.
Ramya, S.M. and Baral, R. (2021) CSR during COVID-19: Exploring Select Organizations’ Intents and Activities. Corporate Governance: The International Journal of Business in Society, 21, 1028-1042. https://doi.org/10.1108/CG-09-2020-0426
Su, F., Liang, X., Cai, S., Chen, S. and Fahad, S. (2021) Assessment of Parent-Subsidiary Companies’ Geographical Distance Effect on Corporate Social Responsibility: A Case of A-Share Listed Companies. Economic Research-Ekonomska Istrazivanja, 35, 4922-4946. https://doi.org/10.1080/1331677X.2021.2019597
El Ghoul, S., Guedhami, O., Ni, Y., Pittman, J. and Saadi, S. (2013) Does Information Asymmetry Matter to Equity Pricing? Evidence from Firms’ Geographic Location. Contemporary Accounting Research, 30, 140-181. https://doi.org/10.1111/j.1911-3846.2011.01147.x
Cashman, G.D., Harrison, D.M., Seiler, M.J. and Sheng, H. (2019) The Impact of Geographic and Cultural Dispersion on Information Opacity. The Journal of Real Estate Finance and Economics, 59, 166-208. https://doi.org/10.1007/s11146-017-9607-2
Sugiyanto, E., Trisnawati, R. and Kusumawati, E. (2021) Corporate Social Responsibility and Firm Value with Profifitability, Firm Size, Managerial Ownership, and Board of Commissioners as Moderating Variables. Riset Akuntansi Dan Keuangan Indonesia, 6, 18-26.
Putri, Z.B. and Budiyanto, B. (2018) Pengaruh Corporate Social Responsibility terhadap nilai perusahaan dengan kepemilikan manajerial sebagai Variabel Moderating. Jurnal Ilmu dan Riset Manajemen, 7, 13-14.